Evidence map›Paper›PMID 31938124›Full record

ArticleInternational journal of clinical and experimental pathology2018

Smurf1-positive expression indicates favorable survival for resected non-small cell lung cancer patients.

He Yu, Dan Li, Ping Zhou, Weimin Li

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

He YuDepartment of Respiratory Medicine, Critical Care Medicine, West China Hospital, Sichuan University Chengdu 610041, Sichuan Province, P. R. China.
Dan LiDepartment of Respiratory Medicine, Critical Care Medicine, West China Hospital, Sichuan University Chengdu 610041, Sichuan Province, P. R. China.
Ping ZhouDepartment of Respiratory Medicine, Critical Care Medicine, West China Hospital, Sichuan University Chengdu 610041, Sichuan Province, P. R. China.
Weimin LiDepartment of Respiratory Medicine, Critical Care Medicine, West China Hospital, Sichuan University Chengdu 610041, Sichuan Province, P. R. China.
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently studies have found that Smurf1 inhibits PIPKIγ-promoted lung cancer cell growth, tumorigenesis, and drug resistance through mediating the ubiquitination and degradation of PIPKIγi2. However, at present there is no study focused on the expression of Smurf1 protein as well as correlations among Smurf1 and lung cancer patients' survival. Therefore, we appraised Smurf1 expression by immmunohistochemistry and analyzed associations with prognosis in resected non-small cell lung cancer (NSCLC) patients. Overall, a number of 175 patients were enrolled in our study. We found that about 53 (30.2%) out of 175 NSCLC patients had Smurf1-pisitive expression. Smurf1-positive expression was significantly associated with lower lymph node metastasis (

Indexed as

non-small cell lung cancerSmurf1survival

Identifiers

PMID31938124
PMCPMC6957962
OpenAlexW3006093153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.